New NEC monitor receives FDA clearance

NEC Display Solutions of America announced today that its MultiSync MD211G5 medical-grade monitor has received FDA clearance for use in tomosynthesis and full field digital mammography (FFDM).

“We are honored to receive FDA clearance for use in tomosynthesis and FFDM in addition to the earlier FDA 510(k) clearance for mammography,” Art Marshall, a senior product manager with NEC, said in a press release. “This demonstrates NEC’s commitment to providing the right products for every modality our customers require.”

The 21-inch, five-megapixel grayscale monitor boasts out-of-the-box factory DICOM calibration designed to promote consistent imaging across the display, the company said.

Click here for the full press release.

John Hocter,

Digital Editor

With nearly a decade of experience in print and digital publishing, John serves as Content Marketing Manager. His professional skill set includes feature writing, content marketing and social media strategy. A graduate of The Ohio State University, John enjoys spending time with his wife and daughter, along with a number of surprisingly mischievous indoor cacti.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.